印度发育性髋关节发育不良监测:印度小儿骨科协会、印度儿科学会、印度国家新生儿学论坛、印度放射与影像协会、印度超声医学与生物学联合会、印度妇产科协会联合会及印度骨科协会共识指南
该共识由印度七个专业协会的多学科专家组制定,旨在通过标准化监测路径提高印度发育性髋关节发育不良(DDH)的早期检出率。推荐所有婴儿在出生时及免疫接种访视时(约6、10、14周及6、9、12、15、18月龄)进行临床髋关节检查,并根据年龄选择Ortolani/Barlow试验、髋外展受限、腿长差异或步态评估;临床异常或不明确时转诊骨科,风险因素阳性而临床正常者按年龄选择超声或X线进一步评估。
要点
- 所有婴儿应在出生时及6、10、14周和6、9、12、15、18月龄免疫接种访视时接受常规临床髋关节检查。
- 小于14周婴儿评估Ortolani和Barlow试验,大于14周评估髋外展受限和腿长差异,行走儿童评估步态。
- 临床检查异常或不明确时推荐转诊骨科进一步评估和管理。
核心结论
- 通过制定和实施标准化监测照护路径,提高印度DDH的早期检出率,从而减少晚期就诊DDH的负担。
研究设计与样本
- 由印度小儿骨科协会、印度儿科学会、印度国家新生儿学论坛、印度放射与影像协会、印度超声医学与生物学联合会、印度妇产科协会联合会及印度骨科协会成员组成的多学科专家组协作制定监测指南。
诊断标准与关键数值
- 所有婴儿在出生时及约6、10、14周和6、9、12、15、18月龄免疫接种访视时进行常规临床髋关节检查。
- 小于14周婴儿评估Ortolani和Barlow试验;大于14周婴儿评估髋外展受限和腿长差异;行走儿童评估跛行。
- 临床检查异常或不明确时,推荐转诊骨科进一步评估和管理。
- 小于6周婴儿Barlow试验阳性但Ortolani试验阴性时,推荐在6周龄时行髋关节超声。
- DDH风险因素包括臀位产、DDH家族史、不安全的髋部包裹方式以及既往任何临床检查中的髋关节不稳定。
临床应用与阅片要点
- 按推荐时间点对所有婴儿进行临床髋关节检查,并记录Ortolani试验、Barlow试验、髋外展受限、腿长差异及步态评估结果。
- 对小于6周且Barlow试验阳性但Ortolani试验阴性的婴儿,在6周龄时安排髋关节超声。
- 对有DDH风险因素但临床检查正常的婴儿,按年龄选择超声或X线检查,小于14周者超声不早于6周龄。
- 临床检查异常或不明确以及影像学检查异常时,转诊骨科医生进一步评估和管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
JUSTIFICATION: When developmental dysplasia of the hip (DDH) is diagnosed during infancy, conservative management is often successful, with good long-term outcomes. In India, DDH is often not diagnosed until walking age and there are limited guidelines for its screening.
PROCESS: A multidisciplinary Expert Group consisting of members of the Paediatric Orthopaedic Society of India, Indian Academy of Pediatrics, National Neonatology Forum of India, Indian Radiological and Imaging Association, Indian Federation of Ultrasound in Medicine and Biology, Federation of Obstetric and Gynaecological Societies of India, and Indian Orthopaedic Association worked collaboratively to develop surveillance guidelines for DDH.
OBJECTIVES: To enhance the early detection rate of DDH in India through development and implementation of a standardized surveillance care pathway, thus reducing the burden of late-presenting DDH.
RECOMMENDATIONS: Routine clinical hip examinations must be performed on all infants at birth and during immunization visits at these approximate time points: 6, 10, and 14 weeks; 6, 9, 12, 15, and 18 months of age. Assessments include Ortolani and Barlow tests for infants <14 weeks; limited hip abduction and leg length discrepancy for infants >14 weeks; and evaluation of limp in walking children. If clinical examination is abnormal or inconclusive, referral to orthopedics for further evaluation and management is recommended. In infants younger than 6 weeks with positive Barlow test but negative Ortolani test, hip ultrasound is recommended at 6 weeks of age. Infants must also be screened for DDH risk factors: breech presentation, family history of DDH, unsafe hip swaddling, and hip instability at any previous clinical examination. In infants with risk factors but normal clinical examination, further evaluation should include ultrasound taken no earlier than 6 weeks of age for infants younger than 14 weeks, ultrasound or X-ray for infants 14 weeks to 6 months of age, and X-ray for infants older than 6 months. Referral to an orthopedic surgeon is recommended if radiological tests are abnormal.
引用
- Aroojis, Anne, Li, et al. Surveillance for Developmental Dysplasia of the Hip in India: Consensus Guidelines From the Pediatric Orthopaedic Society of India, Indian Academy of Pediatrics, National Neonatology Forum of India, Indian Radiological and Imaging Association, Indian Federation of Ultrasound in Medicine and Biology, Federation of Obstetric and Gynaecological Societies of India, and Indian Orthopaedic Association. Indian Pediatr. 2022. PMID: 35348125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。